Inclusion in ASX200 is the least of my points of interest. We will get there when/if we deserve it - if we enter without earning it we will soon get booted out.
We need a satisfactory ROW deal, we need demonstrated Daybue sales, we need encouraging 2591 progress. All our fantastic SP/MC projections are reliant on those reasonable, but yet to be achieved, accomplishments.
IMO, in terms of the future we are still very much speculative, but with an (as ever) extremely positive risk/reward outlook.
Patience and favourable fundamentals outcomes are still required in order to fulfill the potential.
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-4567
-
-
- There are more pages in this discussion • 6,300 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.42 |
Change
-0.100(0.49%) |
Mkt cap ! $2.606B |
Open | High | Low | Value | Volume |
$20.60 | $20.77 | $20.37 | $2.212M | 107.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 120 | $20.41 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.43 | 167 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 84 | 20.410 |
2 | 62 | 20.400 |
5 | 333 | 20.390 |
5 | 228 | 20.380 |
7 | 498 | 20.370 |
Price($) | Vol. | No. |
---|---|---|
20.420 | 16 | 3 |
20.430 | 184 | 9 |
20.440 | 200 | 3 |
20.450 | 863 | 9 |
20.460 | 293 | 5 |
Last trade - 14.01pm 15/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online